Letter re: Reduced-dose radiotherapy for Epstein-Barr virus DNA selected staged III nasopharyngeal carcinoma: A single-arm, phase 2 trial
European Journal of Cancer · 2024
DOI: 10.1016/j.ejca.2023.113459 ↗Kurz gefasst
Klinische Studie (Phase II) in der Zeitschrift European Journal of Cancer, 2024. Verfasst von Erkan Topkan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Faculty of Medicine, Baskent University, Adana, Turkey. Hauptthemen laut MEDLINE: Epstein-Barr Virus Infections, Nasopharyngeal Neoplasms. Die Arbeit nennt 10 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Radiation Oncology, Faculty of Medicine, Baskent University, Adana, Turkey.
- Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Baskent University, Ankara, Turkey; Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, University of Kyrenia, Girne, North Cyprus. Ele…
- Department of Radiation Oncology, Faculty of Medicine, Koc University, Istanbul, Turkey.
- Department of Radiation Oncology, Faculty of Medicine, Bahcesehir University, Istanbul, Turkey.
Zitieren
APA
Topkan, E., Somay, E., Selek, U., & Pehlivan, B. (2024). Letter re: Reduced-dose radiotherapy for Epstein-Barr virus DNA selected staged III nasopharyngeal carcinoma: A single-arm, phase 2 trial. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2023.113459
Vancouver
Topkan E, Somay E, Selek U, Pehlivan B. Letter re: Reduced-dose radiotherapy for Epstein-Barr virus DNA selected staged III nasopharyngeal carcinoma: A single-arm, phase 2 trial. European Journal of Cancer. 2024. doi:10.1016/j.ejca.2023.113459
BibTeX
@article{Topkan2024,
author = {Topkan, Erkan and Somay, Efsun and Selek, Ugur and Pehlivan, Berrin},
title = {Letter re: Reduced-dose radiotherapy for Epstein-Barr virus DNA selected staged III nasopharyngeal carcinoma: A single-arm, phase 2 trial},
journal = {European Journal of Cancer},
year = {2024},
doi = {10.1016/j.ejca.2023.113459}
}
EUVIMED